HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
Colon Cancer Canada Announces Strategy to Increase Capacity for Colon Cancer Screening Colon Cancer Canada, in association with, Mount Sinai Hospital, Sunnybrook Health Sciences Centre and Toronto General Hospital launch the Early Screening...
-
CCNMatthews Newswire; Nov 7, 2006; 700+ Words
...Wait times for colon cancer screening at three...to Colon Cancer Canada's innovative funding...Today, Colon Cancer Canada, in association...chance of developing colon cancer would have been...About Colon Cancer Canada Established in ...
-
-
Callisto Announces Newly Allowed Patent on First-in-Class Drug for Colon Cancer and Other Diseases; Research Data Supports Drug's Potential as Revolutionary, Safe, Non-Toxic Preventative for Cancer and Treatment for Gastro-Intestinal Diseases.
-
Business Wire; Nov 28, 2005; 700+ Words
...in the fight against cancer and other major health...the bowel, including colon cancer. The drug is...the United States and Canada, and is the third most...innovative new drugs to treat cancer and other major diseases...pipeline includes anti-cancer drugs to treat blood, or ...
-
-
Diagnocure announces sponsorship of inaugural undy 5,000 run - Partnership with the Colon Cancer Alliance creates patient awareness of previstage(TM) GCC staging test.
-
PR Newswire; Sep 11, 2008; 700+ Words
...sponsorship of the Colon Cancer Alliance...United States and Canada (after lung...surgery to see if cancer has spread...stage I and II cancers) later develop...high-value cancer diagnostic tests...GCC Colorectal Cancer Staging Test...assay, and in Canada. In ...
-
-
Genomic Health Announces Positive Preliminary Results from QUASAR Validation Study of Oncotype DX(R) Colon Cancer Assay.
-
PR Newswire; Apr 14, 2009; 700+ Words
...recurrence for stage II colon cancer patients following surgery, and that the colon cancer Recurrence Score...from the United States and Canada or +1(706)679-8297...from the United States and Canada or +1(706)645-9291...
-
-
Xillix Announces Year End Financial Results for 2005-Provides Update on Onco-LIFE'TM' Colon Cancer Trial
-
CCNMatthews Newswire; Feb 27, 2006; 700+ Words
...the early detection of cancer, today announced results...TM) international colon cancer trial. "Xillix...LIFE international colon cancer trial and preparing...application) and in Canada (for both lung cancer...Hospital, Toronto, Canada and five U.S. investigators...
-
-
CN Announces it has Donated $250,000 to the Atlantic Cancer Research Institute.
-
M2 Presswire; Apr 25, 2007; 700+ Words
...Watchlist: CN Announces it has Donated...centre in Atlantic Canada dedicated to...number of new cancer cases will increase...trait of all cancers. The funds will...ties to Atlantic Canada and its communities...that supporting cancer research here...Research Council of Canada ...
-
-
InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces US$1.25 Million Private Placement.
-
PR Newswire Europe; Nov 7, 2008; 700+ Words
...BRITISH COLUMBIA, Canada, November 7 /PRNewswire...technology, announces the development of...treatment of colorectal cancer. "Recent experimental...Placement InNexus also announces it intends to issue...that develops in the colon or rectum. The American...070 new cases of colon ...
-
-
InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement.
-
PR Newswire; Nov 7, 2008; 700+ Words
...BRITISH COLUMBIA, Canada, Nov. 7 /PRNewswire...technology, announces the development of...treatment of colorectal cancer. "Recent experimental...Placement InNexus also announces it intends to issue...that develops in the colon or rectum. The American...070 new cases of colon ...
-
-
Pfizer Announces Phase III Trial to Study Sunitinib Malate in Patients with Metastatic Colorectal Cancer.
-
M2 Presswire; Jun 29, 2007; 700+ Words
...Watchlist: Pfizer Announces Phase III Trial...cancer (mCRC) - cancer originating in the colon that has spread...Gastrointestinal Cancer (WCGC) in Barcelona...malate in numerous cancers," said Charles...advanced colorectal cancer through a global...enrolling in Europe, ...
-
-
Oncogene Science announces patent approval on technology for detection of chromosomal translocations in human cancer.
-
PR Newswire; Jul 21, 1987; 700+ Words
ONCOGENE SCIENCE ANNOUNCES PATENT APPROVAL ON...TRANSLOCATIONS IN HUMAN CANCER MANHASSET, N.Y...expression can cause cancer. Patent number 4...with the National Cancer Institute. Oncogene...lung, breast and colon cancer." The company...test in Europe and Canada before the end ...
-
-
AMDL Announces MyGene Granted Distribution Rights for DR-70(R) Cancer Diagnostic Kit in South Korea.
-
PR Newswire; Mar 31, 2003; 700+ Words
...BRC2 for breast cancer. "MyGene is...in Germany, Canada, Taiwan, China...of one or more cancers 84 percent of...include lung, colon, breast, stomach...technologies of human cancer detection kits...same disease, cancer. AMDL is the...humans of up to 13 cancers 84 percent ...
-
-
EXACT Sciences Announces Issuance of Key Patent Covering Vimentin Gene for Colorectal Cancer Screening.
-
Business Wire; Feb 4, 2009; 700+ Words
...for the detection of colon cancer. The issued patent...Compositions for Detecting Colon Cancers," United States Patent...presence of colorectal cancer. Through its license...the United States and Canada with Laboratory Corporation...
-
-
Arius announces new findings in Trop-2 and CD59 CANCER antibody programs - CD59 antibody uses novel approach to "de-cloak" cancers -.
-
BIOTECH Patent News; Sep 1, 2007; 700+ Words
...Toronto, Canada), a biotechnology...approaches in treating cancer. Our Trop-2 antibody...linked to aggressive cancers in the scientific...human pancreatic cancer, inhibiting tumor...models of breast, colon and prostate cancers. The antibody compared...Taxotere in prostate ...
-
-
Genyous Diagnostics Announces New Test to Improve Chance of Surviving Lung Cancer; AQC(TM) MAC Early Detection Test Begins International Clinical Trial.
-
PR Newswire; Aug 11, 2003; 700+ Words
...cancer kills more people than colon, breast, and prostate cancer combined, it is imperative...deployed globally." Lung cancer was responsible for 154,900 deaths, or 28 percent of all US cancer morbidity in 2002, per the...the next four most prevalent cancers: colon (48,100), ...
-
-
AstraZeneca Announces RECENTIN(TM) as Global Trademark for Novel Cancer Treatment, AZD2171.
-
PR Newswire Europe; Jan 10, 2007; 700+ Words
...small cell lung cancer (NSCLC) and advanced colorectal cancer (CRC) - as well...approach in anti-cancer treatment. More importantly...more than breast, colon and prostate cancer...Cancer Institute of Canada (NCIC), is comparing...
-
-
AMDL Announces Jade Pharmaceutical Files for Approval for AMDL's DR-70(R) Cancer Diagnostic Test Kit in China.
-
PR Newswire; Sep 25, 2006; 700+ Words
...in humans of up to 14 cancers 84 percent of the time...13 different types of cancer (lung, breast, stomach, liver, colon, rectal, ovarian...sample size for 9 of the cancers was not statistically...have been conducted in Canada, China, Germany...detect many kinds of cancer using a ...
-
-
Biomira Announces Initiation Of BLP25 Vaccine In Phase II Pilot Study For Prostate Cancer.
-
PR Newswire; Oct 19, 2001; 700+ Words
...Cancer Board, Cross Cancer Institute in Edmonton...treating prostate cancer," stated Alex...MUC1 expressing cancers. Cancers expressing MUC1 include breast, colon, and prostate...trial in 16 sites in Canada and the United Kingdom...small cell lung cancer (NSCLC). ...
-
-
AMDL Announces Its DR-70(R) Cancer Detection Test Will Be Made Available At Major U.S. Laboratory.
-
PR Newswire; Nov 29, 2001; 700+ Words
...the same disease, cancer. AMDL is the inventor...non-invasive cancer blood test, which...humans of up to 13 cancers simultaneously 84...conducted in China, Canada, Taiwan and Turkey. Cancers that can be detected are lung, colon, breast, stomach...R) can detect cancer using a ...
-
-
Lorus Therapeutics announces interim clinical results of GTI-2040 in combination chemotherapy for the treatment of renal cell cancer; - Further clinical development plans to proceed -.
-
PR Newswire; Jan 12, 2004; 700+ Words
...end- stage renal cell cancer in the United States...outcome in renal cell cancer. In the present clinical...2040, in renal cell cancer with the intention of...Hospital in Toronto, Canada. The three remaining...investigate GTI-2040 in colon cancer, prostate cancer...
-
-
Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients With K-RAS or EGFR-Activated Tumours.
-
PR Newswire Europe; Sep 2, 2008; 700+ Words
CALGARY, Canada, September 2...replicates in cancer cells that have...thirds of all cancers have an activated...leading cause of cancer death. More people die of lung cancer than of colon, breast and prostate cancers combined. During...
|
|